Mahzad Akbarpour to Receptors, Immunologic
This is a "connection" page, showing publications Mahzad Akbarpour has written about Receptors, Immunologic.
Connection Strength
0.051
-
Advances in therapeutic targeting of immune checkpoints receptors within the CD96-TIGIT axis: clinical implications and future perspectives. Expert Rev Clin Immunol. 2022 Dec; 18(12):1217-1237.
Score: 0.051